UPL Corporation successfully completes pricing of US$ 300 million senior unsecured notes
(05 Mar 2018)
UPL announced that its wholly owned subsidiary, UPL Corporation (formerly Biowin Corporation) has successfully completed the pricing of its US$ 300 million senior unsecured notes ('Notes') at 4.5 % per annum, due 2028. The Notes have been rated 'BBB-' by Fitch, and 'BBB-' by S&P. An application is filed to the Singapore Stock Exchange for the listing of the Notes. The offering is scheduled to close on 08 March 2018.